Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Glaucoma, Plateau Iris : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Glaucoma, Intraocular Tumors




Patient Education
Glaucoma Center

Glaucoma Overview

Glaucoma Causes

Glaucoma Symptoms

Glaucoma Treatment

Glaucoma FAQs

Understanding Glaucoma Medications




Author: Jim C Wang, MD, Retina/Vitreous Fellow, Department of Ophthalmology, West Virginia University; Cornea/Anterior Segment Subspecialist, Department of Ophthalmology, Kaiser Permanente Fontana Medical Center

Jim C Wang is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, and American Society of Retina Specialists

Coauthor(s): Robert Ritch, MD, Chief of Glaucoma Service, Surgeon Director, Professor, Department of Ophthalmology, New York Eye and Ear Infirmary; Celso Tello, MD, Clinical Assistant Professor, Department of Ophthalmology, New York Eye and Ear Infirmary

Editors: Bradford Shingleton, MD, Assistant Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Martin B Wax, MD, Clinical Professor, Department of Ophthalmology, University of Texas Southwestern Medical School; Vice President, Ophthalmology Research and Development, Head, Ophthalmology Discovery Research, Alcon Labs, Inc; Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri; Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Author and Editor Disclosure

Synonyms and related keywords: plateau iris, plateau iris syndrome, plateau iris configuration

Background

Plateau iris is one of the most common angle-closure glaucomas presenting in younger patients. This condition is characterized by closing of the anterior chamber angle secondary to a large or anteriorly positioned ciliary body that mechanically alters the position of the peripheral iris in relation to the trabecular meshwork.

Pathophysiology

In plateau iris configuration, the pars plicata may be large and anteriorly positioned, mechanically positioning the peripheral iris against the trabecular meshwork. In addition, the iris root is inserted anteriorly on the ciliary face further crowding the anterior chamber angle. The iris crowding of the angle obstructs aqueous flow via the trabecular meshwork and may lead to angle-closure glaucoma.

Except in the rare younger patients (age 20-30s), some degree of pupillary block also is present. Because a component of pupillary block may exist in patients with plateau iris configuration, laser iridotomy should always be performed as the first intervention. If the angle remains capable of closure despite a patent iridotomy, the condition is termed plateau iris syndrome.

A high prevalence of plateau iris configuration has been reported in relatives of patients with plateau iris syndrome. An autosomal dominant inheritance pattern with incomplete penetrance has also been suggested.

Frequency

United States

The exact prevalence of plateau iris is unknown. However, it has been reported to account for more than 50% of patients younger than 60 years with recurrent angle closure. The diagnosis of plateau iris should be suspected when angle closure occurs in patients who are young or myopic and when angle narrowing persists despite iridotomy.

International

In a study from Singapore, plateau iris is found in about one third of primary angle-closure glaucoma suspects after laser iridotomy. 

Mortality/Morbidity

Plateau iris is an important cause of angle-closure glaucoma in patients younger than 50 years.

Sex

Plateau iris is seen most commonly in women.

Age

Patients with plateau iris usually are younger than those with primary angle-closure (relative pupillary block) glaucoma.



History

  • Patients with plateau iris tend to be female, in their 30-50s, hyperopic, and often have a family history of angle-closure glaucoma.
  • Patients may present with angle closure, either spontaneously or after pupillary dilation.
  • More commonly, the diagnosis of plateau iris configuration is made on routine examination.
  • Plateau iris syndrome usually is recognized in the postoperative period when the angle remains persistently narrow in an eye after iridotomy.

Physical

  • Slit lamp examination of patients with plateau iris usually shows normal anterior chamber depth with a flat or slightly convex iris surface.
  • On gonioscopy, the angle is extremely narrowed or closed, with a sharp drop-off of the peripheral iris.
    • When indentation gonioscopy is performed, the double-hump sign is seen.
    • The more peripheral hump is determined by the ciliary body propping up the iris root, and the more central hump represents the central third of the iris resting over the anterior lens surface. The space between the humps represents the space between the ciliary processes and the endpoint of contact of the iris to the anterior lens capsule.
    • More force often is needed to open the angle on indentation gonioscopy than on pupillary block angle closure.
  • Plateau iris syndrome is characterized by persistent angle occludability (spontaneous, in the dark, or after dilation) in an eye with a patent iridotomy. The level of the iris stroma in relation to the angle structures, referred to as the height of the plateau, differentiates the 2 subtypes of plateau iris syndrome.
    • In the complete syndrome, the angle is occluded to the upper trabecular meshwork or the Schwalbe line and intraocular pressure (IOP) rises.
    • Incomplete plateau occludes the angle to mid level, leaving the upper portion of the filtering meshwork open and IOP unchanged. This latter situation is far more common and is clinically important because these patients can develop peripheral anterior synechiae (PAS) and synechial angle closure years after a successful iridotomy. Therefore, patients with open angle after iridotomy should not be assumed to be cured. The angle can narrow further with age, and angle closure can occur years later.

Causes

Plateau iris results from large or anteriorly positioned ciliary processes holding forward the peripheral iris and maintaining its apposition to the trabecular meshwork. The etiology underlying this anterior displacement of the pars plicata is unclear but probably represents an anatomic variant.

No indication exists of any abnormality of the ciliary body that would cause such forward rotation of the ciliary processes. The possibility that the lens-zonule apparatus is pulling the process forward is unlikely because of the observation that in pseudophakic patients the iris processes remain in a forward position, despite the posterior position of the posterior chamber lens.



Glaucoma, Intraocular Tumors

Other Problems to be Considered

Pseudoplateau iris: In pseudoplateau iris, the anterior displacement of the peripheral iris is not caused by an enlarged or anteriorly positioned ciliary body. Cysts of the iris and/or ciliary body neuroepithelium most often are responsible. This condition is distinguished easily from plateau iris because the angle usually is closed in only one quadrant or, if cysts are multiple, at several focal loculations. Ultrasound biomicroscopy is extremely helpful in identifying the underlying mechanism responsible for pseudoplateau iris.

Ciliary body cyst
Iris cyst
Peripheral anterior synechiae
Incomplete iridotomy



Imaging Studies

  • Ultrasound biomicroscopy
    • The configuration of the iris surface, iris root insertion, iridocorneal angle, and ciliary processes can be seen in detail to confirm the clinical findings of plateau iris.
    • Any element of pupillary block also may be confirmed with ultrasound biomicroscopy (UBM) imaging.
  • Optical coherence tomography (OCT) has evolving utility in imaging anterior segment structures and may assist in diagnosing plateau iris.



Medical Care

Surgical management is the primary treatment modality in patients with plateau iris configuration or syndrome. However, pilocarpine may produce iris thinning and facilitate angle opening in some cases.

Surgical Care

Because some degree of pupillary block frequently exists in patients with plateau iris configuration, peripheral laser iridotomy always should be performed as the first intervention in all patients suspected of having plateau iris.

  • A patent iridotomy may be therapeutic in reducing risks of angle closure. However, in some patients, laser iridotomy may not significantly alter the anterior chamber depth or anatomy. Even after a successful iridotomy produces what appears to be a well-opened angle, periodic gonioscopy remains crucial because these patients may have incomplete plateau iris syndrome or the angle may narrow further with age because of the enlargement of the lens. Although usually recognized in the postiridotomy period, plateau iris syndrome may develop years later. Patients with plateau iris configuration should not be assumed to be cured, even though plateau iris syndrome does not develop immediately.
  • If persistent iridotrabecular apposition is present despite a patent iridotomy, the diagnosis is consistent with plateau iris syndrome, and peripheral laser iridoplasty is indicated.
    • Argon laser peripheral iridoplasty (ALPI) is the procedure of choice to effectively open an angle that remains occluded after successful laser iridotomy. The procedure consists of placing laser burns on the surface of the peripheral iris to contract the iris stroma between the site of the burn and the angle. The result is iris stromal tissue contraction and compaction that physically widens the angle and prevents the apposition of the peripheral iris against the trabecular meshwork.
    • ALPI is highly effective, and the effect is maintained for years.  However, even after successful opening of the angle, regular gonioscopic examination remains crucial.  A small proportion of patients may develop reclosure of the angle, which is readily reopened with repeat ALPI. Urrets-Zavalia syndrome (prolonged mydriasis unresponsive to pilocarpine) is an uncommon complication of ALPI that typically resolves spontaneously.1   
  • If angle closure persists despite iridotomy and sufficient peripheral laser iridoplasty, surgical intervention in the form of goniosynechialysis, trabeculectomy, or tube-shunt implantation surgery may be needed to allow bypass of aqueous flow and to control IOP.

Consultations

Consultation and/or comanagement with a glaucoma specialist may be helpful in patients who fail to respond to laser iridotomy and iridoplasty.



Treatment of plateau iris is primarily surgical. However, in patients whose anterior chamber angles remain occludable after properly performed iridotomy and laser peripheral iridoplasty, miotic therapy may be used to prevent angle closure.

Drug Category: Miotics

Miotic agents cause the pupillary sphincter to contract, mechanically pulling the iris away from the trabecular meshwork and opening the anterior chamber angle. In addition, these agents also have an IOP-lowering effect by stimulating contraction of the ciliary muscle and thereby increasing trabecular outflow of aqueous humor. Induced myopia, pupillary constriction, brow ache, and retinal detachment are potential adverse effects of this therapy.

Drug NamePilocarpine (Pilocar, Piloptic, Pilostat, Akarpine, Ocusert Pilo-40)
DescriptionCommercially available as an ophthalmic solution, daily dosing gel, and sustained-release membranes (Ocusert). The symptoms of induced myopia and miosis are best tolerated with the sustained-release Ocusert.
Adult DoseSolution: 1 or 2 gtt tid/qid
Gel: 0.5-inch ribbon in lower conjunctival sac of affected eye(s) qhs
Ocusert Pilo-20 or 40: Insert pledget in inferior palpebral fornix weekly
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; acute inflammatory disease of anterior chamber; peripheral retinal disease
InteractionsMay be ineffective when used concomitantly with nonsteroidal anti-inflammatory agents
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCaution in acute cardiac failure, peptic ulcer, hyperthyroidism, GI spasm, bronchial asthma, Parkinson disease, recent MI, urinary tract obstruction, and hypertension or hypotension



Further Outpatient Care

  • Periodic gonioscopy remains crucial because patients may develop further angle narrowing or closure years after achieving open-angle with patent iridotomy.
  • Routine follow-up screening for development of glaucoma also is recommended.

Complications

  • Plateau iris causes crowding of the anterior chamber angle and may lead to acute or chronic angle-closure glaucoma even in the presence of a patent iridotomy.

Prognosis

  • Patients with plateau iris have a good prognosis in general; however, regular follow-up examinations are needed because angle-closure may develop years after successful iridotomy or iridoplasty.

Patient Education



Medical/Legal Pitfalls

  • Patients must be informed that this is a chronic condition that may recur despite initial treatment success. Regular follow-up examinations need to be emphasized as well as the risk of future development of glaucoma.



Media file 1:  Ultrasound biomicroscopy. (A) In plateau iris, the anterior position of the ciliary body holds the peripheral iris against the trabecular meshwork. (B) The angle is obstructed further in the dark as the peripheral iris thickens with physiologic pupillary dilation.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 2:  Ultrasound biomicroscopy, plateau iris syndrome. (A) Appositional anterior chamber angle in dark condition prior to laser iridotomy. (B) After laser iridotomy, the angle remains occludable. (C) After peripheral laser iridoplasty, the peripheral iris is thinned, opening the angle and significantly reducing the risk of closure.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image



  1. Espana EM, Ioannidis A, Tello C, Liebmann JM, Foster P, Ritch R. Urrets-Zavalia syndrome as a complication of argon laser peripheral iridoplasty. Br J Ophthalmol. Apr 2007;91(4):427-9. [Medline].
  2. Azuara-Blanco A, Spaeth GL, Araujo SV, Augsburger JJ, Terebuh AK. Plateau iris syndrome associated with multiple ciliary body cysts. Report of three cases. Arch Ophthalmol. Jun 1996;114(6):666-8. [Medline].
  3. Barkana Y, Shihadeh W, Oliveira C, Tello C, Liebmann JM, Ritch R. Angle closure in highly myopic eyes. Ophthalmology. Feb 2006;113(2):247-54. [Medline].
  4. Crowston JG, Medeiros FA, Mosaed S, Weinreb RN. Argon laser iridoplasty in the treatment of plateau-like iris configuration as result of numerous ciliary body cysts. Am J Ophthalmol. Feb 2005;139(2):381-3. [Medline].
  5. Etter JR, Affel EL, Rhee DJ. High prevalence of plateau iris configuration in family members of patients with plateau iris syndrome. J Glaucoma. Oct 2006;15(5):394-8. [Medline].
  6. Kumar RS, Baskaran M, Chew PT, Friedman DS, Handa S, Lavanya R, et al. Prevalence of Plateau Iris in Primary Angle Closure Suspects An Ultrasound Biomicroscopy Study. Ophthalmology. Sep 25 2007;[Medline].
  7. Leung CK, Chan WM, Ko CY, Chui SI, Woo J, Tsang MK, et al. Visualization of anterior chamber angle dynamics using optical coherence tomography. Ophthalmology. Jun 2005;112(6):980-4. [Medline].
  8. Liebmann JM, Ritch R. Laser surgery for angle closure glaucoma. Semin Ophthalmol. Jun 2002;17(2):84-91. [Medline].
  9. Liebmann JM, Ritch R. Ultrasound biomicroscopy of the anterior segment. J Am Optom Assoc. Aug 1996;67(8):469-79. [Medline].
  10. Pavlin CJ, Foster FS. Plateau iris syndrome: changes in angle opening associated with dark, light, and pilocarpine administration. Am J Ophthalmol. Sep 1999;128(3):288-91. [Medline].
  11. Pavlin CJ, Ritch R, Foster FS. Ultrasound biomicroscopy in plateau iris syndrome. Am J Ophthalmol. Apr 15 1992;113(4):390-5. [Medline].
  12. Polikoff LA, Chanis RA, Toor A, Ramos-Esteban JC, Fahim MM, Gagliuso DJ, et al. The effect of laser iridotomy on the anterior segment anatomy of patients with plateau iris configuration. J Glaucoma. Apr 2005;14(2):109-13. [Medline].
  13. Ritch R. Plateau iris is caused by abnormally positioned ciliary processes. J Glaucoma. 1992;1:23-26.
  14. Ritch R, Chang BM, Liebmann JM. Angle closure in younger patients. Ophthalmology. Oct 2003;110(10):1880-9. [Medline].
  15. Ritch R, Liebmann JM. Argon laser peripheral iridoplasty. Ophthalmic Surg Lasers. Apr 1996;27(4):289-300. [Medline].
  16. Ritch R, Shields MB, Krupin T. Angle-closure glaucoma: clinical types. In: The Glaucomas. 1996:827-9.
  17. Ritch R, Tham CC, Lam DS. Argon laser peripheral iridoplasty (ALPI): an update. Surv Ophthalmol. May-Jun 2007;52(3):279-88. [Medline].
  18. Ritch R, Tham CC, Lam DS. Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome. Ophthalmology. Jan 2004;111(1):104-8. [Medline].
  19. Tello C, Rothman R, Ishikawa H. Differential diagnosis of the angle-closure glaucomas. Ophthalmol Clin Nor Am. 2000;13:443-53.
  20. Wand M, Grant WM, Simmons RJ, Hutchinson BT. Plateau iris syndrome. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. Jan-Feb 1977;83(1):122-30. [Medline].
  21. Wand M, Pavlin CJ, Foster FS. Plateau iris syndrome: ultrasound biomicroscopic and histologic study. Ophthalmic Surg. Feb 1993;24(2):129-31. [Medline].

Glaucoma, Plateau Iris excerpt

Article Last Updated: Feb 11, 2008